ENHANC3D GENOMICS LTD
SUITE 1, THE JEFFREYS BUILDING, ST JOHN'S INNOVATION PARK, COWLEY ROAD, CAMBRIDGE  CB4 0DS- Active
- Private Limited Company
- Company No. 12423696
- Last Updated: 01 Mar 2024
Company Profile
ENHANC3D GENOMICS LTD was incorporated on Friday, January 24, 2020 as a Private Limited Company with registered address in CAMBRIDGE. ENHANC3D GENOMICS LTD has the status: Active and it's listed in the following category: Research and experimental development on biotechnology. This Private Limited Company has been operating for 5 years 1 month and 1 day.
Name | ENHANC3D GENOMICS LTD |
---|---|
Company number | 12423696 |
Company type | Private Limited Company |
Incorporation date | 24 Jan 2020 |
Status | Active |
Industry (SIC 2007) |
Address
Registered Address |
SUITE 1, THE JEFFREYS BUILDING, ST JOHN'S INNOVATION PARK COWLEY ROAD CAMBRIDGE CB4 0DS |
---|---|
Country Of Origin | UNITED KINGDOM |
Map based on PostCode
Ownership Information
Individuals and organizations with significant control over the business either by owning at least 25% shares or by virtue of significant influence over the business.
Name | Nature of Control |
---|---|
Bioqube Factory Fund I Commv Barricadenplein, B-1000 |
Dates: Tuesday, March 30, 2021 - present
ownership of shares 25 to 50 percent
|
Prof Peter John Fraser Nationality: American |
Dates: Tuesday, December 8, 2020 - Thursday, April 1, 2021
ownership of shares 25 to 50 percent
voting rights 25 to 50 percent
|
Prof Peter John Fraser Nationality: American |
Dates: Friday, January 24, 2020 - Wednesday, August 5, 2020
ownership of shares 25 to 50 percent
voting rights 25 to 50 percent
right to appoint and remove directors
|
Dr Mikhail Spivakov Nationality: British |
Dates: Friday, January 24, 2020 - Wednesday, August 5, 2020
ownership of shares 25 to 50 percent
voting rights 25 to 50 percent
right to appoint and remove directors
|
Dr Stefan Walter Schoenfelder Nationality: German |
Dates: Friday, January 24, 2020 - Wednesday, August 5, 2020
ownership of shares 25 to 50 percent
voting rights 25 to 50 percent
right to appoint and remove directors
|
Accounts and Confirmation
Type of accounts | SMALL |
---|---|
End of financial Year | 31 December |
Next annual accounts due | 30 September 2024, (-148 days left) |
Latest accounts | 31 December 2022 |
Next confirmation statement due | 21 February 2021 |
Last confirmation statement dated | Not available |
Mortgages
No mortgages have been registered against ENHANC3D GENOMICS LTD.
Previous Names
Name | Change Date |
---|---|
ENHANC3D GENOMICS LTD | 24 Jan 2020 |